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A B S T R A C T
We report a 33-year-old Japanese man diagnosed with mixed connective tissue disease (MCTD) who developed
nephrotic proteinuria. Both speckled antinuclear antibody (ANA) and anti-U1 ribonucleoprotein (RNP) antibody
were positive, but anti-double-stranded DNA (dsDNA) antibody and anti-Smith (Sm) antibody were negative,
while complement levels were normal. Renal biopsy revealed membranous glomerulonephritis (MGN) with
diﬀuse thickening of the glomerular basement membrane (GBM) plus spike and bubble formation.
Immunoﬂuorescence demonstrated granular deposits of IgG and C3 along the GBM. Analysis of IgG subclasses
showed predominant deposition of IgG1 and IgG4, unlike typical lupus nephritis in which there is predominant
deposition of IgG1, IgG2, IgG3, and C1q. Electron microscopy identiﬁed numerous large electron-dense deposits
(EDD) of various types in the subepithelial region of the GBM, but there were no EDD localized in the mesangium
or subendothelium. Based on these ﬁndings, MGN was considered to be closely related to MCTD in this patient.
1. Introduction
Mixed connective tissue disease (MCTD) is a connective tissue dis-
order characterized by a high titer of anti-U1 ribonucleoprotein (RNP)
antibody combined with clinical features that are usually seen in sys-
temic lupus erythematosus (SLE) and systemic sclerosis (SSc). While
absence of severe renal disease is a hallmark of MCTD, renal involve-
ment occurs to some extent, with membranous glomerulonephropathy
(MGN) being the most common renal manifestation and nephrotic
proteinuria also being possible [1]. Unlike MCTD, SLE is characterized
by a high titer of anti-ds-DNA antibodies and reduced levels of com-
plement components. Renal manifestations of SLE are frequent, and
some patients develop MGN-like glomerulonephritis [2–4]. However,
the diﬀerences between MGN related to MCTD or LN are poorly un-
derstood. We encountered an MCTD patient with nephrotic proteinuria,
in whom renal biopsy revealed MGN. Based on the ﬁndings in this case,
we discuss the diﬀerences between MCTD-related and LN-related MGN.
(See Table 1.)
2. Case report
In January 2013, a 33-year-old Japanese man was admitted to our
hospital with edema of the legs, weight gain, and sausage-like digits. At
the age of 23 years, Raynaud phenomenon had developed. At age 27,
severe back pain occurred due to left renal vein thrombosis. MCTD was
diagnosed since he also had Raynaud phenomenon, swollen hands, and
a high titer of anti-U1 RNP antibody. Edema of the legs initially oc-
curred in September 2012. The patient had no allergies, drank alcohol
socially, and was a nonsmoker. His mother had rheumatoid arthritis.
On admission, the patient was 165.6 cm tall and weighed 54 kg,
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with a blood pressure of 129/69 mmHg and heart rate of 110/min.
Severe edema was noted at eyelids and lower legs, in addition, swelling
and joint pain of both hands (including proximal and distal inter-
phalangeal joints and metacarpophalangeal joints) were deﬁnite.
Laboratory ﬁndings were as follows (Table1): total protein was 5.4 g/
dL; albumin, 2.9 g/dL; serum creatinine, 0.7 mg/dL and CRP, 0.0 mg/
dL. Immunological tests revealed that speckled type of ANA was 108
index using ELIZA method (normal:< 20). Anti-U1 RNP antibody was
also 133 index using ELIZA method(normal: < 15), but anti-dsDNA
antibody,and anti-Sm antibody. CH50 was 47 U/mL (normal:> 30 U/
mL). Anti-PLA2R antibody was negative. The urinary sediment did not
contain erythrocytes or leukocytes. However, 24-h protein excretion
was 3.4 g. Computed tomography (CT) showed ground-glass opacities
in both the lower lobes of the lungs, but 2-dimensional echocardio-
graphy with Doppler ﬂow studies did not reveal any evidence of pul-
monary hypertension. Biopsy was performed from the lower pole of the
left kidney.
3. Renal biopsy
Light microscopy (LM) demonstrated global sclerosis in 1/35 glo-
meruli. Tubulointerstital ﬁbrosis associated with atrophy occupied 30
to 40% of the cortical region, but there was minimal sclerotic change of
small arteries (Fig. 1a). Examination with periodic acid methenamine-
silver (PAM)-Masson staining identiﬁed diﬀuse thickening of the glo-
merular basement membrane (GBM), with deﬁnite spike and bubble
formation and deposits between the spikes (Fig. 1b), but there was no
mesangial cell proliferation. Immunoﬂuorescence (IF) revealed gran-
ular deposits of IgG and C3 along the GBM, but IgA, IgM, C1q, and C4
were negative. Analysis of IgG subclasses showed that IgG1 and IgG4
were predominant (Fig. 1c). Electron microscopy (EM) detected nu-
merous large electron-dense deposits (EDD) in the subepithelial region
of the GBM, with perpendicular protrusions (i.e., spikes) arising from
the GBM between these deposits. The following types of EDDs were also
noted: EDDs extending from the subendothelial into the subepithelial
region, hump-like EDDs separate from the lamina densa that bulged
toward Bowman's capsule beyond the GBM boundary,and EDDs that
extended toward Bowman's capsule from the subepithelial region
(Fig. 1d). However, there were no EDD localized in the mesangium or
subendothelium. MGN (Stage II and/or III) was diagnosed.
4. Diagnosis
This patient was positive for anti-RNP antibody and speckled ANA,
but was negative for anti-dsDNA antibody and anti-Sm antibody that
are usually positive in SLE. He was also negative for anti-Scl70 anti-
body, anti-centromere antibody, and anti- RNAP III antibody (usually
positive in systemic sclerosis), as well as being negative for anti-Jo-1
antibody (positive in polymyositis). His clinical manifestations included
swelling and pain of joints in the hands, Raynaud phenomenon, and
interstitial lung disease. A deﬁnite diagnosis of MCTD was made ac-
cording to the previous criteria [5].
5. Clinical course
Treatment was started with methylprednisolone (MPSL) (40 mg/
day) and methylprednisolone pulse therapy (1000 mg/day for 3 days)
was given concomitantly. However, proteinuria did not subside, so ta-
crolimus (FK: 1.5 mg/day) and mycophenolate mofetil (MMF:
2000 mg/day) were added, but his proteinuria persisted. MPSL was
switched to dexamethasone (DEX: 4 mg/day), and then was changed to
prednisolone (PSL: 20 mg/day). In addition, the dose of MMF was de-
creased to 1500 mg/day and that of FK was decreased to 1 mg/day.
Thereafter, proteinuria began to decrease. Pneumonia occurred after
eight months of treatment, so MMF and FK were discontinued and PSL
was tapered to 5 mg/day. After 13 months, proteinuria increased to
1.23 g/day. Therefore, FK was restarted at 2 mg/day and PSL was in-
creased to 10 mg/day. Thereafter, his proteinuria subsided to 0.3 g/day
(Fig. 2).
6. Discussion
Various autoantibodies may be detected in patients with SLE, in-
cluding ANA, anti-dsDNA antibody, anti-Sm antibody, anti-RNP anti-
body, and anti- SSA (Ro) antibody. Among these autoantibodies, anti-
dsDNA antibody is most commonly associated with lupus nephritis
(LN), and its titer is usually correlated with disease activity [6]. From
10 to 20% of patients with LN have MGN (classV) [2–4]. It was reported
that anti-Sm antibody is also related to renal disease and this associa-
tion is stronger when anti-dsDNA antibody is positive concomitantly
[7], while LN has not been reported in patients who are negative for
both anti-dsDNA and anti-Sm antibodies. Our patient was negative for
both of these antibodies, which was inconsistent with typical LN.
LN-related MGN was reported to show some diﬀerent histological
features from idiopathic MGN. Concurrent subendothelial or prominent
mesangial deposits are detected by EM, as also seen in the proliferative
forms of lupus nephritis. Glomerular deposition of all of IgG, IgM, IgA,
C3, and C1q (called “full house”) may be seen [8]. In LN, deposition of
IgG1, IgG2 and IgG3 is predominant, while predominance of IgG4 is
seen in idiopathic MGN [9].
Table 1
Laboratory ﬁndings on admission.
Case Nomal range Case Normal range
Blood Anti-centromere antibody Negative Negative
White blood cell 104/μl 6.2 3.4 to 9.2 Anti-RNAP III body Negative Negative
Red blood cell 106/μl 4.22 4.00 to 5.66 Anti SS-A antibody Negative Negative
Platelet 104/μl 22 14.1 to 32.7 Anti-PLA2R antibody Negative Negative
Total protein g/dl 5.4 6.9 to 8.4 PR3-ANCA U/ml < 10 < 2
Albumin g/dl 2.9 3.9 to 5.2 MPO-ANCA U/ml < 10 < 3.5
Urea nitrogen mg/dl 31 8 to 21 C3 mg/dl 83 86 to 160
Creatinine mg/dl 0.7 0.6 to 1.1 C4 mg/dl 21 17 to 45
Creatinine clearance ml/min 86.1 > 90 CH50 U/ml 47 30 to 50
Total cholesterol mg/dl 275 122 to 240 IgG mg/dl 567 870 to 1700
CRP mg/dl 0 0.0–0.3 IgA mg/dl 140 110 to 470
ANA IU/ml 108 < 20 IgM mg/dl 27.8 35 to 220
RF U/ml 3 0–15 Immuno-electrophoresis Negative Negative
Anti U1-RNP antibody IU/ml 133 < 15 Bence-Jones protein Negative Negative
Anti-dsDNA antibody IU/ml < 10 < 12 Urine
Anti-Sm antibody Negative Negative Red blood cell /HPF < 1 < 1
Anti Jo-1 antibody Negative Negative White blood cell /HPF < 1 < 1
Anti-Scl70 antibody Negative Negative Protein g/day 3.4 < 0.1
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In MCTD patients, renal biopsy displays immune complex glomer-
ulonephritis and the changes are similar to those in LN. Ito studied the
renal histology of 6 children with MCTD, reporting that 2 of them had
MGN, 3 had MPG, and 4 showed a mixture of MGN and MPG [1].
Ichikawa analyzed the national Japanese renal biopsy database (20,523
patients) and identiﬁed 5 patients with MCTD, 3 of whom had MGN
[10]. Omokawa reported that MGN shows predominance of IgG2 in
patients with MCTD, while lupus-associated MGN is typically positive
for IgG1, IgG2, IgG3, C1q, C4 and C3, but they did not report EM
ﬁndings [11]. In contrast, our patient predominantly showed deposition
of IgG (IgG1 and IgG4).
Its reported that EM revealed subepithelial, intramembranous, and
mesangial deposits in patients with MCTD [1], but did not give precise
details.
Diﬀerences between MGN in MCTD and LN may be summarized as
the following; MCTD-related MGN shows the predominant stain of IgG1
and IgG4 on this case, and the predominant stain of IgG2 according to






Fig. 1. Renal biopsy ﬁndings
a: Tubulointerstitial ﬁbrosis and atrophy occupies 30 to 40% of the cortical region. Blue shows connective tissue. (Masson trichrome stain)
b: Spike and bubble formation in the glomerular basement membrane (GBM) is recognized on periodic acid methenamine-silver (PAM)-Masson staining. Large arrow shows a spike
(black). Small arrow shows a deposit (blue-white).
c: Immunoﬂuorescence(IF) revealed granular deposits of IgG and C3 along the GBM. Analysis of IgG subclasses showed predominance of IgG1 and IgG4.
d: On electron microscopy (EM), there were numerous large electron-dense deposits (EDD: large arrows) in the subepithelial region of the GBM, with perpendicular protrusions (spikes
shown by small arrows) arising from the GBM between the EDD.
e: Various types of EDDs were found in this patient, including deposits that expanded from the subendothelial to subepithelial region(large arrow), hump-like EDDs(small arrow)separate
from the lamina densa that bulged toward Bowman's capsule beyond the GBM boundary,and EDDs that extended toward Bowman's capsule from the subepithelial region (*). (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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mesangial deposits on EM. While, on lupus-associated MGN, IF shows
the positive stain of IgG3 and C1q, and IgG3 ﬁx complement component
of classical complement pathway such as C1q, C3 and C4, resulting in
an inﬂux of inﬂammatory cells. As well as subepithelial EDDs, con-
current subendothelial or mesangial deposits are present on EM.
In conclusion, we evaluated glomerulonephritis in a patient with
MCTD. Renal biopsy showed MGN with diﬀuse spikes and bubbles of
the GBM (stage II and/or III). In addition, analysis of IgG subclasses
identiﬁed predominant deposition of IgG1 and IgG4, while EM revealed
various types of large subepithelial EDD. These histological ﬁndings
were not consistent with a diagnosis of LN-associated MGN or idio-
pathic MGN, and the patient's MGN was considered to be related to
MCTD.
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